TrueTicker

NIFTY 500 › Healthcare

Healthcare · NIFTY 500

Emcure Pharmaceuticals Ltd.

EMCURE on NSE · 19 Nov 2026

NIFTY 500

2,344.70 ▲ +0.42 % on the day

Emcure Pharmaceuticals Ltd. (EMCURE) closed at ₹2,344.70 on 19 Nov 2026, up 0.42 % on the day. Over the past year it is up 75.3 %; it stands 2.4 % below its 52-week high; it trades above its 200-day average. Its P/E is 40.7 on the last four quarters' profit. In Q2 FY27 (Jul-Sep 2026), profit grew 33.7 % and revenue grew 24.3 % from a year earlier, as the company reported. It is part of the NIFTY 500, in the Healthcare sector.

Overview Technical Risk & rank Quality Results Accounts Filings Guidance & governance

EMCURE · last year19 Nov 2026

The line uses prices adjusted for splits, bonuses and similar events.

1 week+1.3 %
1 month+32.7 %
3 months+25.1 %
1 year+75.3 %
From 52-week high-2.4 %distance from its highest close of the last year
200-day averageAboveprice above or below its 200-day average
P/E40.7on the last four quarters' profit
Typical daily turnover20.6₹ cr, median day of the last 60
Delivery58 %of traded shares taken into demat (not squared off)

Results in short

Q2 FY27 (Jul-Sep 2026), as the company reported it.

Revenue2,820₹ cr in the quarter, +24.3 % YoY
Profit326₹ cr in the quarter, +33.7 % YoY
Profit margin11.5 %profit as a share of revenue
Return on equity20.5 %ROE: last four quarters' profit on shareholders' funds

All 10 quarters

Emcure Pharmaceuticals Ltd. is part of the NIFTY 500. Figures are consolidated, from the company's results filed with NSE. Quality checks and outlook cover NIFTY 50 companies only, for now.

Ask Sensei

Ask Sensei

Ask about any NIFTY 500 company in plain words. The answer comes from its own filings, with the page behind every point.

For example:

See a sample answer

Start free Sign in